Musculoskeletal Pain clinical trials

Explore recruiting musculoskeletal pain clinical trials.

Recruiting musculoskeletal pain studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Musculoskeletal Pain trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Systemic Bioavailability and Bioequivalence of Topical Diclofenac Fysioline 23.2 mg/g gel compared with Diclofenac Diethylamine - Voltaren Forte 2.32% gel

Finland

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

Letrozole for Estrogen/Progesterone Receptor positive low-grade serous Epithelial ovarian cancer. A randomized phase III trial. LEPRE Trial

Italy, Czechia

Therapeutic confirmatory (Phase III) EU CTIS Study details

Randomized, double-blind, Placebo-controlled, 2x2 cross over study assessing the efficacy and safety of cANnabidiol oral solution for joint pain of adjuvant enDOcrine theRApy in patients with early breast cancer (PANDORA)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Randomized, double-blind, Placebo-controlled, 2x2 cross over study assessing the efficacy and safety of cANnabidiol oral solution for joint pain of adjuvant enDOcrine theRApy in patients with early breast cancer (PANDORA)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase I, Randomised, Open Label, Single Center, Single Oral Dose, Three Treatment, Three Period, Three Sequence, Change-over Bioequivalence Study of Paracetamol Orodispersible Tablet 500 mg (Haleon) to assess Bioequivalence with Alvedon 500 mg Film-Coated Tablet (Haleon, Sweden) and Panadol 500 mg Film-Coated Tablet (Haleon, Australia) in Healthy Adult Subjects Under Fasting Conditions

Germany

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

Musculoskeletal Pain trials by city

Musculoskeletal Pain in Toronto Musculoskeletal Pain in Vancouver Musculoskeletal Pain in Montreal Musculoskeletal Pain in Calgary Musculoskeletal Pain in Edmonton Musculoskeletal Pain in Ottawa Musculoskeletal Pain in Winnipeg Musculoskeletal Pain in Quebec City Musculoskeletal Pain in Hamilton Musculoskeletal Pain in Kitchener Musculoskeletal Pain in London Musculoskeletal Pain in Halifax Musculoskeletal Pain in New York Musculoskeletal Pain in Los Angeles Musculoskeletal Pain in Chicago Musculoskeletal Pain in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease